DZ Bank’s Kura Oncology KURA Stock Holding History

DZ Bank’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-40,094	Closed	-$752K	–	980
2018 Q1	$752K	Buy	+40,094	New	+$780K	﹤0.01%	717

Other funds holding KURA

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DZ Bank's KURA Position: Q2 2018 in Review

DZ Bank sold out of Kura Oncology (KURA) in Q2 2018, closing a stake of 40,094 shares — an estimated $752K sold.

DZ Bank first reported a position in KURA in Q1 2018 and held it in 1 quarter. The position peaked at $752K in Q1 2018. 107 funds tracked by Wall St. Rank hold KURA as of Q2 2018.

DZ Bank reported no remaining Kura Oncology position as of Q2 2018 after selling out during the quarter.
DZ Bank sold 40,094 Kura Oncology shares in Q2 2018, an estimated $752K.
DZ Bank first reported a position in Kura Oncology in Q1 2018 and held it in 1 quarter.
DZ Bank's Kura Oncology position peaked at $752K in Q1 2018.
107 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2018.

Based on DZ Bank's 13F filing for Q2 2018, filed 14 Aug 2018.